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Abstract
Simple, rapid, cost-effective, sensitive and extractive spectrophotometric methods were developed for the determination of two
antifungal drugs (i.e., sertaconazole nitrate (SER) and miconazole nitrate (MCO)) in pure and dosage forms. The methods are based
on the formation of ion-pair complexes between the drugs and acid dyes (i.e., bromocresol purple (BCP), bromophenol blue (BPB)
and methyl orange (MO)) in acidic buffer solutions. The formed complexes were extracted with chloroform and measured at 410,
416 and 427 nm for SER and at 408, 415 and 426 nm for MCO using BCP, BPB and MO, respectively. The analytical parameters
and their effects on the reported systems were investigated. Beer’s law was obeyed in the 1.0–20 and 1.0–24 g mL−1 ranges for
SER and MCO, respectively. The composition of the ion pairs was determined to be 1:1. The molar absorptivity, Sandell sensitivity,
limits of detection and limits of quantification were calculated. Other method validation parameters, such as precision, accuracy,
robustness, ruggedness and selectivity, were satisfactory. The proposed methods have been successfully applied for the analysis of
the studied drugs in their pure and dosage forms. Statistical comparison of the results with the reference methods indicated excellent
agreement and no significant difference in accuracy and precision.
© 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Taibah University. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1.  Introduction
Imidazole drugs are a group of antifungal drugs that
have broad-spectrum antifungal activities against a wide
range of fungi that cause various mycotic infections
[1]. The members of this group are structurally related
and have similar physicochemical properties and
mechanisms of action. The members of the imidazole
group are miconazole (base or nitrate salt) and ser-behalf of Taibah University. This is an open access article under the
taconazole (base or nitrate salt) [1]. Although there
are a number of imidazole drugs currently available,
their efficacy may not be completely achieved for
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MFig. 1. Chemical structur
he treatment of human mycoses due to their poor
ater solubility and limited dissolution properties
hat are associated with slow drug absorption, lead-
ng to inadequate and variable bioavailability [1,2].
he chemical structures of the studied imidazoles
ntifungal drugs (i.e., sertaconazole (SER); (±)-1-{2,4-
ichloro--[(7-chlorobenzo[b] thien-3-yl)methoxy]
henethyl}imidazole nitrate and miconazole (MCO),
-[2,4-dichloro--(2,4-dichlorobenzyloxy) phenethyl]
midazole nitrate) are shown in Fig. 1.
A survey of the literature revealed that several analyt-
cal methods have been reported for the determination
f the studied drugs in the pure drug form, pharmaceuti-
al dosage forms and biological samples using liquid
hromatography, either in single or combined form
3–18], capillary zone electrophoresis methods [19],
lectrochemical methods [20], non-aqueous titration
2], spectrofluorimetric methods [16,21] and spectro-
hotometric methods [21–32].
Visible spectrophotometry has remained competi-
ive in the area of chromatographic techniques for
harmaceutical analysis due to its simplicity and cost
ffectiveness, sensitivity and selectivity, fair accuracy,
recision and available in most quality control laborato-
ies. In addition, this method does not require the costly
nstrumentation that is required for the published HPLC
ethods.
Extractive spectrophotometric procedures are pop-
lar due to their sensitivity in the assay of drugs,
nd therefore, ion-pair extractive spectrophotometry has
eceived considerable attention for the quantitative deter-
ination of many pharmaceutical compounds [33–40].
In the current study, the development of accurate,
eproducible, simple, precise, sensitive and economical
xtractive spectrophotometric method for the determina-
ion of both antifungal drugs (SER and MCO) in their
ure and dosage forms was investigated based on the for-
ation of chloroform soluble ion–associate complexes
etween the studied drugs and acid dyes (BCP, BPB or
O).studied antifungal drugs.
2.  Experimental
2.1.  Apparatus
All of the absorption spectra were recorded on
a Kontron Unikon 930 (UV–vis) spectrophotometer
(Germany) equipped with 10 mm matched quartz cells
at a scanning speed of 200 nm/min and a band width
of 2.0 nm. The pH values of the various buffer solutions
were confirmed using a Hanna pH-metre instrument (pH
211) (Romania) equipped with a combined glass calomel
electrode.
2.2.  Materials  and  reagents
All of the chemicals and reagents were of analytical
grade and used without further purification. In addition,
all of the solutions were prepared fresh daily, and the
water was doubly distilled.
2.2.1.  Materials
Pure grade sertaconazole nitrate (SER) was provided
by October Pharma Drug Company, Egypt, and the
miconazol nitrate (MCO) working standard was supplied
by Amriya Pharmaceutical Industries Co., Egypt.
2.2.2. Pharmaceutical  formulations
All of the pharmaceutical preparations were obtained
from commercial sources in the local markets (i.e., Der-
mofix cream labelled to contain 2.0 mg SER/g (October
Pharma. Co., Egypt, Ferrer International, SA, Spain),
Miconaz cream labelled to contain 2.0% MCO/15 g
(Medical Union Pharmaceuticals, Abu-Sultan, Ismailia,
Egypt), Micoban cream labelled to contain 2.0%
MCO/15 g (Amriya Pharmaceutical Industries Co.,
Egypt)).2.2.3. Preparation  of  stock  standard  solutions
Stock standard solutions with concentrations of
100 g mL−1 and 1.0 ×  10−3 mol L−1 of SER or MCO,
h Univ28 A.A. Gouda et al. / Journal of Taiba
were prepared by dissolving an exact mass of pure drug
in bidistilled water containing a few drops of 0.1 mol L−1
hydrochloric acid and completed to 100 mL with bidis-
tilled water. The standard solutions were stable for at
least one week without alteration when maintained in
amber collared bottles and stored in a refrigerator when
not in use.
2.2.4. Reagents
Bromocresol purple (BCP), bromophenol blue (BPB)
and methyl orange (MO) (BDH Chemicals Ltd., Poole,
England) were used without further purification.
The stock solutions (1.0 ×  10−3 mol L−1) of the
reagents were prepared by dissolving the appropriate
weight of each reagent in 10 mL of 96% ethanol followed
by dilution to 100 mL with bidistilled water. These solu-
tions were stable for at least 1 week when maintained in
the refrigerator.
A series of buffer solutions consisting of KCl–HCl
(pH = 1.5–4.2), NaOAc–HCl (pH = 1.99–4.92),
NaOAc–AcOH (pH = 3.0–5.6) and potassium hydrogen
phthalate–HCl (pH = 2.0–7.0) were prepared according
to previously published standard methods [41].
2.3.  General  procedures
2.3.1.  For  SER
Aliquots (0.1–2.4 mL) of the standard SER solution
(100 g mL−1) were transferred to 10-mL measuring
flasks, and 2.0 mL of acetate buffer at a pH of 3.0
and 4.0 containing BCP, BPB or MO, respectively,
were added. Then, 2.0 mL of the reagent solution
(1.0 ×  10−3 mol L−1) was added. The total volume of
each solution was brought up to 10 mL with bidis-
tilled water. The formed ion–associate complexes were
extracted twice with 10 mL of chloroform by shaking
for 2.0 min. Then, the solution was allowed to stand for
clear separation of the two phases, and the chloroform
layer was passed through anhydrous sodium sulphate.
The absorbance of the yellow collared complexes was
measured at 410, 416 and 427 nm using BCP, BPB and
MO, respectively, against a corresponding reagent blank
that was similarly prepared. All of the measurements
were performed at room temperature (25 ±  2 ◦C). The
procedures were repeated for other analyte aliquots, and
calibration plots were drawn to calculate the amount of
SER in the unknown analyte samples.2.3.2. For  MCO
Aliquots (0.1–2.0 mL) of the standard MCO solution
(100 g mL−1) were transferred to 10 mL measuring
flasks and 2.0 mL of acetate buffer at a pH of 3.0ersity for Science 10 (2016) 26–37
containing BCP, BPB or MO, respectively, were
added. Then, 2.0 mL of the reagent solution
(1.0 ×  10−3 mol L−1) was added. The total vol-
ume of each solution was completed to 10 mL with
bidistilled water. The formed ion–associate complexes
were extracted twice with 10 mL of chloroform by
shaking for 2.0 min. Then, the solution was allowed
to stand for clear separation of the two phases, and
the chloroform layer was passed through anhydrous
sodium sulphate. The absorbance of the yellow collared
complexes was measured at 408, 415 and 426 nm using
BCP, BPB and MO, respectively, against a correspond-
ing reagent blank that was similarly prepared. All of
the measurements were performed at room temperature
(25 ±  2 ◦C). The procedures were repeated for the other
analyte aliquots, and calibration plots were drawn to
calculate the amount of MCO in the unknown analyte
samples.
2.4.  Applications  to  pharmaceutical  formulations
An accurately weighed portion of the cream or topical
solution samples equivalent to 20 mg of the drug was
shaken and gently heated in ethanol until the sample
was completely dissolved and then filtered. The resulting
clear solution was diluted to 50 mL with ethanol. Then,
an appropriate dilution of the solution was prepared with
water, and the recommended procedure was followed.
The standard addition method was also employed for
the accurate determination of the content of SER and
MCO.
2.5.  Stoichiometric  relationship
The stoichiometric ratios of the ion–associate com-
plexes formed between the studied drugs and the
reagents were determined by applying the continuous
variation [42] and molar ratio [43] methods at the wave-
lengths of maximum absorbance. In the continuous
variation method, equimolar solutions were employed
(i.e., 5.0 ×  10−4 mol L−1 standard solutions of drug and
5.0 ×  10−4 mol L−1 solutions of dye). A series of solu-
tions were prepared in which the total volume of the
studied drugs and the dye was maintained at 2.0 mL.
The drug and reagent were mixed in various com-
plementary proportions (0:2, 0.2:1.8, 0.4:1.6, . .  ., 2:0,
inclusive) and completed to volume in a 10 mL cali-
brated flask with the appropriate solvent for extraction
according to the previously mentioned procedure. In the
molar ratio method, the concentrations of SER and MCO
(5.0 ×  10−4 mol L−1) are held constant by using 1.0 mL,
and the concentrations of the dyes (5.0 ×  10−4 mol L−1)
h University for Science 10 (2016) 26–37 29
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Fig. 3. Absorption spectra of the ion-pair complexes of 14 and
18 g mL−1 SER and MCO with 1.0 × 10−3 mol L−1 BPB reagent
against the reagent blank.A.A. Gouda et al. / Journal of Taiba
re regularly varied (0.2–2.4 mL). The absorbance of the
repared solutions was measured at the optimum wave-
ength for each complex.
.  Results  and  discussion
.1.  Absorption  spectra
The nitrogenous drugs are present in their posi-
ively charged protonated forms, and the anionic dyes
ith a sulphonephthalein group primarily exist in their
nionic form at pH ≥  2.5. Therefore, when treated with
n acid dye with acidic buffer solutions in a pH range of
.5–5.0, a yellow ion-pair complex, which is extracted
ith chloroform, is formed. The absorption spectra of
he ion-pair complexes, which were formed between
ER or MCO and the reagents, were measured in
he 350–550 nm range against the blank solution. The
aximum absorbances of the ion-pair complexes were
ocated at 410, 416 and 427 nm for SER and 408, 415 and
26 nm for MCO using BCP, BPB and MO, respectively
Figs. 2–4).
.2.  Optimum  reaction  conditions  for  complex
ormation
The methods were optimized to achieve complete
eaction formation, the highest sensitivity and maxi-
um absorbance. The reaction conditions of the ion-pairomplex were determined by studying the results from
reliminary experiments with varying conditions, such
s the pH of buffer, type of organic solvent, volume of
ig. 2. Absorption spectra of the ion-pair complexes of 10 and
6 g mL−1 SER and MCO with 1.0 × 10−3 mol L−1 BCP reagent
gainst a reagent blank.
Fig. 4. Absorption spectra of ion-pair complexes of 20 and
24 g mL−1 SER and MCO with 1.0 × 10−3 mol L−1 MO reagent
against reagent blank.
the dye, reaction time and temperature, for the extraction
of the ion-pair complexes.
3.2.1.  Effects  of  pH  on  ion-pair  formation
The effect of pH on the formation of the drug–reagent
complex was studied by extracting the collared com-
plexes in the presence of various buffers. For SER, the
maximum colour intensity and highest absorbance value
were observed using the NaOAc–AcOH buffer at a pH of
3.0 and 4.0 using (BCP or BPB) and MO, respectively.
For MCO, the highest absorbance values were observed
at a pH of 3.0 using BCP, BPB or MO (Fig. 5). In addi-
tion, 2.0 mL of the optimum buffer solutions afforded
the maximum absorbance with reproducible results.
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3.2.2.  Effect  of  the  extracting  solvents
The effect of several organic solvents (i.e., chloro-
form, carbon tetrachloride, methanol, ethanol, acetoni-
trile, n-butanol, benzene, acetone, ethyl acetate, diethyl
ether, toluene, dichloromethane and chlorobenzene) was
studied to achieve effective extraction of the collared
species from the aqueous phase. Among the studied
reagents, chloroform was determined to be the most suit-
able solvent for quantitative extraction of the collared
ion-pair complexes. The experimental results indicated
that a double extraction with a total volume of 10 mL of
chloroform yielded the maximum absorbance intensity,
stable absorbance for the studied drugs and considerably
lower extraction ability for the reagent blank with the
shortest time to reach equilibrium between both phases.
3.2.3. Effects  of  reagents  concentration
The effect of the reagents was studied by measuring
the absorbance of the solutions containing a fixed con-
centration of the studied drugs and varied amounts of
the respective reagents. The maximum colour intensity
of the complex was achieved with 2.0 mL of each of
the reagent solutions (1.0 ×  10−3 mol L−1). However, a
larger volume of the reagent had no pronounced effect
on the absorbance of the formed ion-pair complexes
(Fig. 6).
3.2.4. Effect  of  time  and  temperature
The optimum reaction time was investigated from0.5 to 5.0 min by following the colour development
at ambient temperature (25 ±  2 ◦C). Complete colour
intensity was achieved after 2.0 min of mixing for each
of the complexes. The effect of temperature on thermation between 14 g mL−1 SER and BCP, BPB and MO reagents
collared complexes was investigated by measuring the
absorbance values at different temperatures. The col-
lared complexes were stable up to 35 ◦C. At higher
temperatures, the drug concentration increased due to
the volatile nature of chloroform. For all of the reagents,
the absorbance remains stable for at least 12 h at room
temperature.
3.3.  Stoichiometric  relationship
Job’s method of continuous variation [42] of equimo-
lar solutions was employed, and a 5.0 ×  10−4 mol L−1
standard solution of the drugs and a 5.0 ×  10−4 mol L−1
solution of BCP, BPB or MO were used. A series of solu-
tions was prepared in which the total volume of the drug
and reagent was maintained at 2.0 mL. The absorbance
was measured at the optimum wavelength.
The molar ratio of the reagents (drug: dye) in the
ion-pair complexes was determined by the continuous
variations method (Job’s method) (Fig. 7). The results
indicated that 1:1 (drug: dye) ion-pair complexes were
formed due to electrostatic attraction between the posi-
tively charged protonated SER+ or MCO+ and negatively
charged BCP−, BPB or MO−. The extraction equilib-
rium can be represented as follows:
SER+ +  D− ↔  SER+D− ↔  SER+D−where SER and D represent the protonated SER and
the anion of the dye, respectively, and the subscript (aq)
and (org) refer to the aqueous and organic phases, respec-
tively (Scheme 1).
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ig. 6. Effect of the volume of the BCP, BPB and MO reagents (1.0 ×
.4.  Method  of  validation
.4.1.  Linearity
Under the studied experimental conditions for
ER and MCO determination, standard calibration
urves with reagents were constructed by plotting the
bsorbance as a function of the concentration. The statis-
ical parameters are provided in the regression equation
alculated from the calibration graphs. The linearity of
he calibration graphs was confirmed by the high cor-
elation coefficients (r) and the small y-intercept values
f the regression equations. The apparent molar absorp-
ivities of the resulting collared ion-pair complexes and
elative standard deviation of the response factors for
ach proposed spectrophotometric method were also cal-
ulated and are listed in Table 1. The molar absorptivity
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ig. 7. Job’s method of continuous variation plot for the reaction of SER with 10  M) reagent
ol L−1) on ion-pair complex formation with 14 g mL−1 MCO.
was BCP > BPB > MO ion-pair complexes for both drugs
(SER and MCO).
3.4.2. Sensitivity
The limits of detection (LOD) and quantitation (LOQ)
for the proposed methods were calculated using the fol-
lowing equation [44,45]:
LOD = 3s
k
and LOQ = 10s
k
where s is the standard deviation of the response of the
blank or the standard deviation of the intercepts of the
regression lines and k is the sensitivity (i.e., the slope of
the calibration plot). According to the formula, the limits
of detection for SER were determined to be 0.21, 0.29
and 0.55 g mL−1 using BCP, BPB and MO methods,
.5 0.6 0.7 0.8 0.9 1
rug (Vd/ Vd + Vr)
BCP
BPB
MO
 dyes: BCP, BPB and MO, [drug] = [dye] = 5.0 × 10−4 mol L−1.
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following equation:SER- BPB io n-pair 
Scheme 1. Proposed reaction mechanism for th
respectively, and for MCO, the LODs were determined
to be 0.25, 0.28, and 0.57 g mL−1 using BCP, BPB and
MO methods, respectively. The limit of quantitations for
SER were determined to be 0.70, 0.97 and 1.83 g mL−1
using BCP, BPB and MO methods, respectively, and
for MCO, the LOQs were determined to be 0.83, 0.93
and 1.90 g mL−1 using BCP, BPB and MO methods,
respectively (Table 1). Therefore, according to the lower
values of the detection limits, the sensitivity of the pro-
posed methods is higher than that of the previously
reported spectrophotometric methods.3.4.3. Accuracy  and  precision
To evaluate the accuracy and precision of the pro-
posed methods, solutions containing three different
concentrations of each of the studied drugs wereplex
air complex formation between SER and BPB.
prepared. The assay procedure was analysed in six repli-
cates, and the relative standard deviation given as a
percentage (RSD%) was obtained within the same day to
evaluate the repeatability (intra-day precision) and over
five different days to evaluate the intermediate preci-
sion (inter-day precision). The analytical results of the
intra-day and inter-day precision and accuracy are sum-
marized in Tables 2 and 3. Low values for the relative
standard deviation of the precision and relative error
(RE%) of the accuracy of the proposed methods wereRE% =
[
founded  −  added
added
]
×  100
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Table 1
Statistical analysis of the calibration graphs and analytical data in the determination of SER and MCO using the proposed methods.
Parameters SER MCO
BCP BPB MO BCP BPB MO
Wavelengths λmax (nm) 410 416 427 408 415 426
pH 3.0 3.0 4.0 3.0 3.0 3.0
Beer’s law limits (g mL−1) 1.0–10 1.0–18 2.0–20 1.0–18 1.0–16 2.0–24
Molar absorptivity ε,
(L/mol−1 cm−1) × 104
1.612 1.870 1.602 1472 3.33 1.482
Sandell’s sensitivity
(ng cm−2)
31.07 26.78 31.26 32.55 14.39 32.33
log Kf 4.962 ± 0.342 4.817 ± 0.279 5.026 ± 0.326 4.947 ± 0.251 5.156 ± 0.178 4.89 ± 0.273
Regression equationa
Intercept (a) 0.0029 −0.0028 −0.0005 −0.0034 −0.0037 0.0039
Slope (b) 0.0311 0.0383 0.0319 0.0379 0.0713 0.00298
Correlation coefficient (r) 0.9994 0.9998 0.9998 0.9995 0.9998 0.9997
LOD (g mL−1)b 0.21 0.29 0.55 0.25 0.28 0.57
LOQ (g mL−1)b 0.70 0.97 1.83 0.83 0.93 1.90
Mean ± SD 100.10 ± 1.09 99.95 ± 1.24 100.05 ± 1.20 99.86 ± 1.02 100.04 ± 0.95 99.90 ± 0.92
RSD% 1.09 1.24 1.20 1.02 0.95 0.92
RE% 1.15 1.30 1.26 1.07 0.997 0.97
t-testc 0.60 0.74 0.63 0.42 0.16 0.38
F-testc 1.84 1.42 1.52 1.27 1.41 1.56
a A = a + bC, where C is the concentration in g mL−1 and A is the absorbance units.
sorptivi
spective
t
r
3
i
(
T
I
M
B
B
Mb LOD, limit of detection; LOQ, limit of quantification; ε, molar ab
c The theoretical values of t and F at P = 0.05 are 2.571 and 5.05, re
These results for the accuracy and precision indicate
hat the proposed methods exhibit good repeatability and
eproducibility.
.4.4.  Robustness  and  ruggedness
The robustness of the method were evaluated by mak-
ng small incremental changes in the volumes of the dye
2.0 ±  0.2 mL), the volumes of the buffer (2.0 ±  0.2 mL)
able 2
ntra-day and inter-day precision and accuracy data for SER obtained using th
ethod Added
(g mL−1)
Intra-day 
Recovery
%
Precision
RSD%a
Accuracy
RE%
Confidenc
limitb
CP 2.0 100.10 0.79 0.10 2.002 ±
6.0 99.50 1.17 −0.50 5.97 ±
10 100.40 1.28 0.40 10.04 ±
PB 4.0 99.70 0.62 −0.30 3.988 ±
10 99.30 0.96 −0.70 9.93 ±
16 100.20 1.65 0.20 16.032 ±
O 5.0 99.60 0.81 −0.40 4.98 ±
10 100.30 1.65 0.30 10.03 ±
20 99.70 1.92 −0.30 19.94 ±
a Mean of six determination, RSD%, percentage relative standard deviation
b Confidence limit at 95% confidence level and five degrees of freedom (t =ty.
ly.
and the reaction times (2 ±  0.5 min), and the effect
of these changes on the absorbance of the collared
systems was studied. These changes had a negligi-
ble influence on the results, which was revealed by
the small intermediate precision values expressed as
RSD (≤3.0%). The ruggedness of the method was
demonstrated by performing the analysis with three
analysts as well as by performing the analysis with
e proposed methods.
Inter-day
e Recovery
%
Precision
RSD%a
Accuracy
RE%
Confidence
limitb
 0.017 99.70 0.68 −0.30 1.994 ± 0.014
 0.073 99.30 0.84 −0.70 5.958 ± 0.053
 0.135 99.40 1.50 −0.60 9.94 ± 0.156
 0.026 100.50 0.56 0.50 4.02 ± 0.024
 0.100 99.60 0.95 −0.40 9.96 ± 0.099
 0.278 99.40 1.160 −0.60 15.904 ± 0.194
 0.042 99.40 0.75 −0.60 4.97 ± 0.039
 0.174 99.70 1.10 −0.30 9.97 ± 0.115
 0.402 99.50 1.75 −0.50 19.9 ± 0.366
; RE%, percentage relative error.
 2.571).
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Table 3
Intra-day and inter-day precision and accuracy data for MCO obtained using the proposed methods.
Method Added
(g mL−1)
Intra-day Inter-day
Recovery
%
Precision
RSD%a
Accuracy
RE%
Confidence
limitb
Recovery
%
Precision
RSD%a
Accuracy
RE%
Confidence
limitb
BCP 4.0 99.80 0.78 −0.20 3.992 ± 0.033 99.40 0.68 −0.60 3.976 ± 0.028
10 99.10 1.35 −0.90 9.91 ± 0.140 99.80 0.94 −0.20 9.98 ± 0.098
16 100.20 1.80 0.20 16.032 ± 0.303 99.50 1.32 −0.50 15.92 ± 0.221
BPB 4.0 99.60 0.54 −0.40 3.984 ± 0.023 100.20 0.46 0.20 4.008 ± 0.019
10 99.70 1.26 −0.30 9.97 ± 0.132 99.10 0.94 −0.90 9.91 ± 0.098
16 99.20 1.94 −0.80 15.872 ± 0.323 99.90 1.24 −0.10 15.984 ± 0.208
MO 6.0 100.50 0.70 0.50 6.03 ± 0.044 99.40 0.55 −0.60 5.964 ± 0.034
12 99.60 1.15 −0.40 11.952 ± 0.144 100.30 0.89 0.30 12.036 ± 0.112
24 100.20 1.70 0.20 24.048 ± 0.429 99.70 1.40 −0.30 23.928 ± 0.352
eviation
om (t =a Mean of six determination, RSD%, percentage relative standard d
b Confidence limit at 95% confidence level and five degrees of freed
a single analyst on three different instruments in the
same laboratory. The intermediate precision values
(RSD) of this study were ≤3.0%, indicating acceptable
ruggedness.
3.4.5. Effects  of  interference
To assess the usefulness of the method, the effect
of diluents, excipients and additives that often accom-
pany SER and MCO in its dosage forms (i.e., starch,
lactose, glucose, saccharose, talc, sodium chloride, tita-
nium dioxide, and magnesium stearate) was studied. The
results indicated that there was no interference from the
excipients and additives, indicating a high selectivity for
the determination of the studied SER and MCO in its
dosage forms.
3.5.  Analysis  of  pharmaceutical  formulationsThe proposed methods have been successfully
applied to the determination of SER and MCO in phar-
maceutical dosage forms. Six replicate determinations
Table 4
Application of the standard addition technique for the determination of SER a
Sample Taken
(g mL−1)
BCP BPB 
Added
(g mL−1)
Recoverya
(%)
Added
(g mL−1
Dermofix cream 2.0 – 99.60 – 
2.0 99.10 2.0 
4.0 99.80 6.0 
8.0 100.40 10 
12 98.80 14 
14 99.00 18 ; RE%, percentage relative error.
 2.571).
were performed. In addition, to confirm the validity of
the proposed methods, the dosage forms were tested for
possible interference using the standard addition method
(Table 4). There was no significant difference between
the slopes of the calibration curves and the standard
addition methods. Therefore, the excipients in the phar-
maceutical dosage forms of SER and MCO did interfere
in the analysis of SER and MCO. The results were com-
pared to those obtained using the previously reported
methods for the determination of SER and MCO [2].
Based on Student’s t-value and variance ratio F-value at
the 95% confidence level, statistical analysis indicated
no significant difference between the accuracy and preci-
sion of the proposed methods and the previously reported
methods for pharmaceutical formulations [45]. The
results indicated that Student’s t- and F-values at the 95%
confidence level did not exceed the theoretical values,
which confirmed the good agreement between the results
obtained from the proposed methods and the reference
methods with respect to the accuracy and precision
(Table 4).
nd MCO in dosage forms using the proposed methods.
MO Official
method [2]
)
Recoverya
(%)
Added
(g mL−1)
Recoverya
(%)
98.70 – 100.10
99.50 4.0 99.70
100.30 10 100.60
100.50 16 99.20
99.20 22 100.30
99.60 26 99.50
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Table 4 (Continued)
Sample Taken
(g mL−1)
BCP BPB MO Official
method [2]
Added
(g mL−1)
Recoverya
(%)
Added
(g mL−1)
Recoverya
(%)
Added
(g mL−1)
Recoverya
(%)
Mean ± SD 99.45 ± 0.599 99.63 ± 0.674 99.90 ± 0.525 99.50 ± 0.73
RSD% 0.602 0.677 0.525
V 0.359 0.455 0.276
t-valueb 0.12 0.29 1.0
F-valueb 1.09 1.17 1.90
Miconaz cream 2.0 – 99.10 – 100.40 – 99.20
2.0 100.40 2.0 100.20 4.0 100.80
4.0 99.00 6.0 99.10 10 99.50
8.0 98.50 10 99.60 16 99.30
12 99.50 14 99.20 22 100.60
14 99.80 18 99.40 26 99.90
Mean ± SD 99.38 ± 0.668 99.65 ± 0.536 99.88 ± 0.68 99.64 ± 0.46
RSD% 0.668 0.536 0.68
V 0.446 0.287 0.462
t-valueb 0.72 0.03 0.654
F-valueb 2.11 1.36 2.19
Micoban cream 2.0 – 99.60 – 99.30 – 99.10
2.0 99.10 2.0 98.90 4.0 99.70
4.0 99.80 6.0 99.00 10 99.50
8.0 98.70 10 99.40 16 98.60
12 98.60 14 99.20 22 99.40
14 99.30 18 98.50 26 99.30
Mean ± SD 99.18 ± 0.48 99.05 ± 0.327 99.27 ± 0.383 99.08 ± 0.67
RSD% 0.48 0.327 0.383
V 0.23 0.107 0.147
t-valueb 0.27 0.09 0.55
F-valueb 1.95 4.20 3.06
a Average of six determinations.
b The theoretical values of t and F are 2.57 and 5.05, respectively, at the confidence limit at the 95% confidence level and five degrees of freedom
(
4
i
q
i
s
r
i
t
t
m
p
o
e
i
f
ep = 0.05).
.  Conclusion
This paper describes the application of an extractive
on-pair complexation reaction with acid dyes for the
uantification of two antifungal drugs (SER and MCO)
n pure and dosage forms. In comparison to the existing
pectrophotometric methods, the proposed methods are
elatively simple, rapid, cost-effective, free from auxil-
ary reagents and more sensitive for the determination of
he studied drugs in pure and dosage forms. In addition,
he proposed methods are free from the tedious experi-
ental steps, such as heating, that are employed in the
reviously reported methods. The most attractive feature
f these methods is their relative freedom from interfer-
nce by the usual diluents and excipients in amounts far
n excess of their normal occurrence in pharmaceutical
ormulations. The statistical parameters and the recov-
ry data indicate good accuracy and precision of themethods. Therefore, the validated methods could be use-
ful for routine quality control assays of the studied drugs
in the raw pharmaceutical materials and dosage forms.
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